Christopher Behme

Person

Jamestown, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted azoanthracene derivatives and intermediates for prepara...
- Patent number 9,175,003
- Issue date Nov 3, 2015
- vTv Therapeutics LLC
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 9,120,813
- Issue date Sep 1, 2015
- vTv Therapeutics LLC
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted azoanthracene derivatives, pharmaceutical compositions,...
- Patent number 8,987,295
- Issue date Mar 24, 2015
- TransTech Pharma, LLC
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 8,933,222
- Issue date Jan 13, 2015
- TransTech Pharma, LLC
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 8,703,766
- Issue date Apr 22, 2014
- TransTech Pharma, LLC
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 8,524,708
- Issue date Sep 3, 2013
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted azoanthracene derivatives, pharmaceutical compositions,...
- Patent number 8,383,644
- Issue date Feb 26, 2013
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 7,906,507
- Issue date Mar 15, 2011
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 7,790,714
- Issue date Sep 7, 2010
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxadiazoanthracene compounds for the treatment of diabetes
- Patent number 7,727,983
- Issue date Jun 1, 2010
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl compounds, compositions, and methods of use
- Patent number 7,544,699
- Issue date Jun 9, 2009
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl and heteroaryl compounds and methods to modulate coagulation
- Patent number 7,122,580
- Issue date Oct 17, 2006
- TransTech Pharma, Inc.
- Adnan M. M. Mjalli
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Substituted Azoanthracene Derivatives and Intermediates for Prepara...
- Publication number 20150148539
- Publication date May 28, 2015
- TransTech Pharma, LLC
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxadiazoanthracene Compounds for the Treatment of Diabetes
- Publication number 20150087640
- Publication date Mar 26, 2015
- TransTech Pharma, LLC
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxadiazoanthracene Compounds for the Treatment of Diabetes
- Publication number 20140187769
- Publication date Jul 3, 2014
- TransTech Pharma, LLC
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES
- Publication number 20130317015
- Publication date Nov 28, 2013
- TRANSTECH PHARMA, INC.
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions,...
- Publication number 20130096150
- Publication date Apr 18, 2013
- TRANSTECH PHARMA, INC.
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS,...
- Publication number 20110160198
- Publication date Jun 30, 2011
- High Point Pharmaceuticals, LLC
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES
- Publication number 20110039837
- Publication date Feb 17, 2011
- TRANSTECH PHARMA, INC.
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES
- Publication number 20100324033
- Publication date Dec 23, 2010
- TRANSTECH PHARMA, INC.
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES
- Publication number 20100197677
- Publication date Aug 5, 2010
- TRANSTECH PHARMA, INC.
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxadiazoanthracene Compounds For The Treatment Of Diabetes
- Publication number 20090306063
- Publication date Dec 10, 2009
- Trans Tech. Pharma. Inc.
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl and heteroaryl compounds and methods to modulate coagulation
- Publication number 20060276518
- Publication date Dec 7, 2006
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl and heteroaryl compounds, compositions, and methods of use
- Publication number 20050059705
- Publication date Mar 17, 2005
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aryl and heteroaryl compounds and methods to modulate coagulation
- Publication number 20040110832
- Publication date Jun 10, 2004
- Adnan M.M. Mjalli
- C07 - ORGANIC CHEMISTRY

Christopher Behme

Person

Patents Grantslast 30 patents

Substituted azoanthracene derivatives and intermediates for prepara...

Oxadiazoanthracene compounds for the treatment of diabetes

Substituted azoanthracene derivatives, pharmaceutical compositions,...

Oxadiazoanthracene compounds for the treatment of diabetes

Oxadiazoanthracene compounds for the treatment of diabetes

Oxadiazoanthracene compounds for the treatment of diabetes

Substituted azoanthracene derivatives, pharmaceutical compositions,...

Oxadiazoanthracene compounds for the treatment of diabetes

Oxadiazoanthracene compounds for the treatment of diabetes

Oxadiazoanthracene compounds for the treatment of diabetes

Aryl and heteroaryl compounds, compositions, and methods of use

Aryl and heteroaryl compounds and methods to modulate coagulation

Patents Applicationslast 30 patents

Substituted Azoanthracene Derivatives and Intermediates for Prepara...

Oxadiazoanthracene Compounds for the Treatment of Diabetes

Oxadiazoanthracene Compounds for the Treatment of Diabetes

OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES

Substituted Azoanthracene Derivatives, Pharmaceutical Compositions,...

SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS,...

OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES

OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES

OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF DIABETES

Oxadiazoanthracene Compounds For The Treatment Of Diabetes

Aryl and heteroaryl compounds and methods to modulate coagulation

Aryl and heteroaryl compounds, compositions, and methods of use

Aryl and heteroaryl compounds and methods to modulate coagulation